Interdisciplinary Analysis of HIV-Specific CD8+ T Cell Responses against Variant Epitopes Reveals Restricted TCR Promiscuity

HIV-1–specific CTL responses play a key role in limiting viral replication. CTL responses are sensitive to viral escape mutations, which influence recognition of the virus. Although CTLs have been shown to recognize epitope variants, the extent of this cross-reactivity has not been quantitatively investigated in a genetically diverse cohort of HIV-1–infected patients. Using a novel bioinformatic binding prediction method, we aimed to explain the pattern of epitope-specific CTL responses based on the patients’ HLA genotype and autologous virus sequence quantitatively. Sequences covering predicted and tested HLA class I-restricted epitopes (peptides) within the HIV-Gag, Pol, and Nef regions were obtained from 26 study subjects resulting in 1492 patient-specific peptide pairs. Epitopes that were recognized in ELISPOT assays were found to be significantly more similar to the autologous virus than those that did not elicit a response. A single substitution in the presented epitope decreased the chance of a CTL response by 40%. The impact of sequence similarity on cross-recognition was confirmed by testing immune responses against multiple variants of six selected epitopes. Substitutions at central positions in the epitope were particularly likely to result in abrogation of recognition. In summary, the presented data demonstrate a highly restricted promiscuity of HIV-1–specific CTL in the recognition of variant epitopes. In addition, our results illustrate that bioinformatic prediction methods are useful to study the complex pattern of CTL responses exhibited by an HIV-1–infected patient cohort and for identification of optimal targets for novel therapeutic or vaccine approaches.

[1]  D. Ge,et al.  HLA-C cell surface expression and control of HIV / AIDS correlate with a variant upstream of HLA-C , 2009 .

[2]  R. Koup,et al.  Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response. , 2009, Blood.

[3]  Todd M. Allen,et al.  HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition , 2009, Journal of Virology.

[4]  Xiping Wei,et al.  Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection1 , 2009, The Journal of Immunology.

[5]  Philippe Froguel,et al.  Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). , 2009, The Journal of infectious diseases.

[6]  H. Schuitemaker,et al.  Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection , 2009, AIDS.

[7]  Morten Nielsen,et al.  Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods , 2009, Bioinform..

[8]  Bin Li,et al.  HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition , 2008, Journal of Virology.

[9]  Philip J. R. Goulder,et al.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.

[10]  Morten Nielsen,et al.  Broadly Immunogenic HLA Class I Supertype-Restricted Elite CTL Epitopes Recognized in a Diverse Population Infected with Different HIV-1 Subtypes1 , 2008, The Journal of Immunology.

[11]  Morten Nielsen,et al.  Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for “Holes” in the T Cell Repertoire , 2008, PloS one.

[12]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[13]  O. Lund,et al.  NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.

[14]  Jacques Fellay,et al.  A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.

[15]  D. Nixon,et al.  Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol , 2007, Journal of Virology.

[16]  S. Oka,et al.  Altering Effects of Antigenic Variations in HIV-1 on Antiviral Effectiveness of HIV-Specific CTLs1 , 2007, The Journal of Immunology.

[17]  D. Nixon,et al.  Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape , 2007, PloS one.

[18]  E. Rosenberg,et al.  T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. , 2006, International immunology.

[19]  D. Cornforth,et al.  HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently1 , 2006, The Journal of Immunology.

[20]  Tao Dong,et al.  Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope , 2006, Nature Immunology.

[21]  J. Goedert,et al.  AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis , 2005, Nature Medicine.

[22]  Galit Alter,et al.  High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level , 2005, AIDS.

[23]  Todd M. Allen,et al.  The Majority of Currently Circulating Human Immunodeficiency Virus Type 1 Clade B Viruses Fail To Prime Cytotoxic T-Lymphocyte Responses against an Otherwise Immunodominant HLA-A2-Restricted Epitope: Implications for Vaccine Design , 2005, Journal of Virology.

[24]  Daniel C. Douek,et al.  T Cell Cross-Reactivity and Conformational Changes during TCR Engagement , 2004, The Journal of experimental medicine.

[25]  A. Sette,et al.  Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced CTL1 , 2004, The Journal of Immunology.

[26]  Derek Middleton,et al.  New allele frequency database: www.allelefrequencies.net , 2003 .

[27]  Feng Gao,et al.  Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.

[28]  R. Brunham,et al.  HLA-A and HLA-B in Kenya, Africa: allele frequencies and identification of HLA-B*1567 and HLA-B*4426. , 2002, Tissue antigens.

[29]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[30]  F. Buseyne,et al.  The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes. , 2001, International immunology.

[31]  Bette T. Korber,et al.  Immune control of HIV: the obstacles of HLA and viral diversity , 2001, Nature Immunology.

[32]  E. Rosenberg,et al.  Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection , 2001, The Journal of experimental medicine.

[33]  H. Etlinger,et al.  the Journal of Immunology , 2006 .

[34]  J. Yewdell,et al.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.

[35]  M A Nowak,et al.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.

[36]  R. Germain,et al.  Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. , 1997, Human immunology.

[37]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[38]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[39]  G. Shaw,et al.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.

[40]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[41]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[43]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[44]  Hidde L. Ploegh,et al.  Peptide selection by MHC class I molecules , 1991, Nature.